Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Gene Ther. 2013 Mar 28;20(9):913–921. doi: 10.1038/gt.2013.14

Figure 2.

Figure 2

Secondary elevation of β-glucuronidase activity in Brain, Liver, Heart, Spleen, Kidney, and Lung from untreated and treated MPS IIIB mice. Mean activity levels +SEM for each group relative to the Normal NO TX group are depicted in the graphs. Group designations are identical to those in Figure 1. (* p<0.05 ** p<0.01, *** p<0.001, **** p<0.0001compared to MPS IIIB NO TX group)